About Biossil
Biossil is an AI native biopharma company that advances late-stage programs for life-threatening diseases. It uses an applied AI drug discovery platform to create specialized treatments for distinct patients. Biossil brings resuscitated drugs to market and expands its capacity for clinical development.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Toronto, Canada
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
biossil.co
Domain Registered Date
May 21, 2023
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $153,000,000 · Venture Round
The Globe and Mail
- Capital Raise
Raised $3,700,000 · Seed
fundraisingfox.com
- Milestone
Website domain registered
biossil.co
Investors & Backers
Abu Dhabi Investment Council
Duke University
Founders Fund
Golden Ventures
Modern Capital
OpenAI Startup Fund
Panache Ventures
Quiet Capital
Staircase Ventures
Funding History
Venture Round
· Sep 28, 2026
$153,000,000 The Globe and Mail
Seed
· Apr 20, 2026
$3,700,000 fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026